<?xml version="1.0" encoding="UTF-8"?>
<p>Treatment advances have improved health and survival for persons living with HIV (PLWH), as well as opportunities to prevent transmission.[
 <xref rid="pone.0215965.ref001" ref-type="bibr">1</xref>–
 <xref rid="pone.0215965.ref004" ref-type="bibr">4</xref>] However, along the care continuum there are many challenges to maximizing the individual and public health benefits of treatment,[
 <xref rid="pone.0215965.ref005" ref-type="bibr">5</xref>–
 <xref rid="pone.0215965.ref011" ref-type="bibr">11</xref>] and outcomes remain persistently suboptimal throughout the US, with 15% of the estimated 1.11 million PLWH being undiagnosed and only 57.9% experiencing viral load suppression within six months of diagnosis (VLS).[
 <xref rid="pone.0215965.ref012" ref-type="bibr">12</xref>, 
 <xref rid="pone.0215965.ref013" ref-type="bibr">13</xref>] Although achieving better care continuum outcomes than other large US cities, New York City (NYC) has to make further progress on VLS in order to meet UNAIDS 90-90-90 targets.[
 <xref rid="pone.0215965.ref014" ref-type="bibr">14</xref>] In 2016, of an estimated 87,700 PLWH in New York City (NYC) 4.2% were undiagnosed, and 80% of diagnosed PLWH achieved VLS.[
 <xref rid="pone.0215965.ref015" ref-type="bibr">15</xref>]
</p>
